Abstract
IntroductionThe optimal trial design for assessing novel therapies in paediatric IBD (PIBD) is a subject of intense ongoing global discussions and debate among the different stakeholders. However, there is a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have